Intercept Pharma (ICPT)

Intercept Pharma (ICPT) Stock Price & Analysis


ICPT Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$8.82 - $21.86
Previous Close$11.19
Average Volume (3M)1.18M
Market Cap
Enterprise Value$1.11B
Total Cash (Recent Filing)$63.02M
Total Debt (Recent Filing)$705.23M
Price to Earnings (P/E)1.8
Aug 03, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)6.35
Shares Outstanding41,687,084
10 Day Avg. Volume2,376,772
30 Day Avg. Volume1,175,997
Standard Deviation0.22
Financial Highlights & Ratios
Price to Book (P/B)6.54
Price to Sales (P/S)6.86
Price to Cash Flow (P/CF)-2.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.76
Enterprise Value/Gross Profit3.89
Enterprise Value/Ebitda-7.07
Price Target Upside66.55% Upside
Rating ConsensusHold
Number of Analyst Covering12



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Intercept Pharma’s price range in the past 12 months?
Intercept Pharma lowest stock price was $8.82 and its highest was $21.86 in the past 12 months.
    What is Intercept Pharma’s market cap?
    Currently, no data Available
    When is Intercept Pharma’s upcoming earnings report date?
    Intercept Pharma’s upcoming earnings report date is Aug 03, 2023 which is in 58 days.
      How were Intercept Pharma’s earnings last quarter?
      Intercept Pharma released its earnings results on Apr 27, 2023. The company reported -$0.77 earnings per share for the quarter, missing the consensus estimate of -$0.647 by -$0.123.
        Is Intercept Pharma overvalued?
        According to Wall Street analysts Intercept Pharma’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Intercept Pharma pay dividends?
          Intercept Pharma does not currently pay dividends.
          What is Intercept Pharma’s EPS estimate?
          Intercept Pharma’s EPS estimate is -$0.55.
            How many shares outstanding does Intercept Pharma have?
            Intercept Pharma has 41,687,084 shares outstanding.
              What happened to Intercept Pharma’s price movement after its last earnings report?
              Intercept Pharma reported an EPS of -$0.77 in its last earnings report, missing expectations of -$0.647. Following the earnings report the stock price went down -12.923%.
                Which hedge fund is a major shareholder of Intercept Pharma?
                Among the largest hedge funds holding Intercept Pharma’s share is Caxton Associates LP. It holds Intercept Pharma’s shares valued at 1M.


                  Intercept Pharma Stock Smart Score

                  The Intercept Pharma stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Intercept Pharma

                  Intercept Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics in treating chronic liver diseases. Its product pipeline is OCALIVA which is used for the treatment of primary biliary cholangitis, nonalcoholic steatohepatitis, primary sclerosing cholangitis, and biliary atresia. The company was founded by Mark E. Pruzanski and Roberto Pellicciari on September 4, 2002 and is headquartered in New York, NY.


                  Top 5 ETFs holding ICPT

                  Market Value
                  Smart Score
                  Vanguard Health Care ETF
                  iShares Core S&P Total U.S. Stock Market ETF
                  iShares NASDAQ US Biotechnology UCITS ETF
                  Fidelity MSCI Health Care Index ETF
                  iShares Russell 3000 ETF
                  Up to five ETFs with an Outperform Smart Score that hold ICPT. The ETFs are listed according to market value of ICPT within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Aurinia Pharmaceuticals
                  Corbus Pharmaceuticals
                  Enanta Pharmaceuticals

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis